BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21136284)

  • 21. [The role of statins in the treatment of heart failure].
    Eren M
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):501-11. PubMed ID: 20098048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
    Kerst LL; Mauro VF
    Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure.
    Bielecka-Dabrowa A; Fabis J; Mikhailidis DP; von Haehling S; Sahebkar A; Rysz J; Banach M
    Trends Pharmacol Sci; 2018 Apr; 39(4):331-353. PubMed ID: 29502887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.
    Waters DD
    J Cardiol; 2010 Mar; 55(2):155-62. PubMed ID: 20206067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?
    von Haehling S; Anker SD
    Heart; 2005 Jan; 91(1):1-2. PubMed ID: 15604317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis.
    Bonsu KO; Kadirvelu A; Reidpath DD
    Syst Rev; 2013 Apr; 2():22. PubMed ID: 23618535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Heart; 2008 Sep; 94(9):1138-40. PubMed ID: 18703694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W; Gmiński J
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
    Anker SD; Clark AL; Winkler R; Zugck C; Cicoira M; Ponikowski P; Davos CH; Banasiak W; Zardini P; Haass M; Senges J; Coats AJ; Poole-Wilson PA; Pitt B
    Int J Cardiol; 2006 Sep; 112(2):234-42. PubMed ID: 16846656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin treatment for patients with heart failure.
    Tang WH; Francis GS
    Nat Rev Cardiol; 2010 May; 7(5):249-55. PubMed ID: 20234351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin therapy in heart failure: prognostic effects and potential mechanisms.
    Shanes JG; Minadeo KN; Moret A; Groner M; Tabaie SA
    Am Heart J; 2007 Oct; 154(4):617-23. PubMed ID: 17892981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins in heart failure--With preserved and reduced ejection fraction. An update.
    Tousoulis D; Oikonomou E; Siasos G; Stefanadis C
    Pharmacol Ther; 2014 Jan; 141(1):79-91. PubMed ID: 24022031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations of statins in heart failure: inflammatory biomarkers and hormones.
    Khan BV; Rajagopalan S
    Heart Fail Clin; 2008 Apr; 4(2):171-6. PubMed ID: 18433697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case for statin therapy in chronic heart failure.
    van der Harst P; Böhm M; van Gilst WH; van Veldhuisen DJ
    Clin Res Cardiol; 2008 Mar; 97(3):139-46. PubMed ID: 18060376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
    Lavie CJ; Mehra MR
    Congest Heart Fail; 2009; 15(4):157-8. PubMed ID: 19627287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.